Immix Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMMX and other ETFs, options, and stocks.About IMMX
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
CEOIlya Rachman
CEOIlya Rachman
Employees21
Employees21
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded2012
Founded2012
Employees21
Employees21
IMMX Key Statistics
Market cap143.38M
Market cap143.38M
Price-Earnings ratio-5.38
Price-Earnings ratio-5.38
Dividend yield—
Dividend yield—
Average volume774.38K
Average volume774.38K
High today$4.47
High today$4.47
Low today$4.20
Low today$4.20
Open price$4.27
Open price$4.27
Volume644.04K
Volume644.04K
52 Week high$4.60
52 Week high$4.60
52 Week low$1.34
52 Week low$1.34
Stock Snapshot
Immix Biopharma(IMMX) stock is priced at $4.30, giving the company a market capitalization of 143.38M. It carries a P/E multiple of -5.38.
On 2025-11-20, Immix Biopharma(IMMX) stock traded between a low of $4.20 and a high of $4.47. Shares are currently priced at $4.30, which is +2.4% above the low and -3.8% below the high.
Immix Biopharma(IMMX) shares are trading with a volume of 644.04K, against a daily average of 774.38K.
In the last year, Immix Biopharma(IMMX) shares hit a 52-week high of $4.60 and a 52-week low of $1.34.
In the last year, Immix Biopharma(IMMX) shares hit a 52-week high of $4.60 and a 52-week low of $1.34.
People also own
Based on the portfolios of people who own IMMX. This list is generated using Robinhood data, and it’s not a recommendation.